Whipple made simple for surgical pathologists: Orientation, dissection, and sampling of pancreaticoduodenectomy specimens for a more practical and accurate evaluation of pancreatic, distal common bile duct, and ampullary tumors

American Journal of Surgical Pathology

Volumn 38, Issue 4, 2014, Pages 480-493

  Adsay, N Volkan ^a   Basturk, Olca ^d   Saka, Burcu ^a   Bagci, Pelin ^a   Ozdemir, Denizhan ^a   Balci, Serdar ^a   Sarmiento, Juan M ^b   Kooby, David A ^b   Staley, Charles ^b   Maithel, Shishir K ^b   Everett, Rhonda ^a   Cheng, Jeanette D ^c   Thirabanjasak, Duangpeng ^e   Weaver, Donald W ^e  

^a EMORY UNIVERSITY HOSPITAL   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c PIEDMONT HOSPITAL   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e WAYNE STATE UNIVERSITY   (United States)

Author keywords

Ampulla; Common bile duct; Grossing; Pancreas; Pancreaticoduodenectomy; Whipple

Indexed keywords

ARTICLE; BILE DUCT TUMOR; HUMAN; METHODOLOGY; PANCREAS TUMOR; PANCREATICODUODENECTOMY; VATER PAPILLA;

AMPULLA OF VATER; COMMON BILE DUCT NEOPLASMS; HUMANS; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY;

EID: 84897028658     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0000000000000165     Document Type: Article

References (41)

1. Birkmeyer JD, Siewers AE, Finlayson EV, et al. Hospital volume and surgical mortality in the United States. N Engl J Med. 2002;346: 1128-1137.
2. Finks JF, Osborne NH, Birkmeyer JD. Trends in hospital volume and operative mortality for high-risk surgery. N Engl J Med. 2011; 364:2128-2137.
3. Bruzoni M, Johnston E, Sasson AR. Pancreatic incidentalomas: Clinical and pathologic spectrum. Am J Surg. 2008;195:329-332; discussion 332.
4. Hopt U, Keck T. Pancreatic incidentalomas. Correct assessment and therapy. Chirurg. 2007;78:713-720.
5. Basturk O, Coban I, Adsay NV. Pancreatic cysts: Pathologic classification, differential diagnosis, and clinical implications. Arch Pathol Lab Med. 2009;133:423-438.
6. Staley CA, Cleary KR, Abbruzzese JL, et al. The need for standardized pathologic staging of pancreaticoduodenectomy specimens. Pancreas. 1996;12:373-380.
7. Luttges J, Zamboni G, Kloppel G. Recommendation for the examination of pancreaticoduodenectomy specimens removed from patients with carcinoma of the exocrine pancreas. A proposal for a standardized pathological staging of pancreaticoduodenectomy specimens including a checklist. Dig Surg. 1999;16:291-296.
8. Chatelain D, Flejou JF. Pancreatectomy for adenocarcinoma: Prognostic factors, recommendations for pathological reports. Ann Pathol. 2002;22:422-431.
9. Verbeke CS, Gladhaug IP. Resection margin involvement and tumour origin in pancreatic head cancer. Br J Surg. 2012;99: 1036-1049.
10. Verbeke CS, Leitch D, Menon KV, et al. Redefining the R1 resection in pancreatic cancer. Br J Surg. 2006;93:1232-1237.
11. Verbeke CS, Menon KV. Redefining resection margin status in pancreatic cancer. HPB (Oxford). 2009;11:282-289.
12. The Royal College of Pathologists of United Kingdom. Standards and Datasets for Reporting Cancers. Data Set for the Histopathological Reporting of Carcinomas of the Pancreas, Ampulla of Vater and Common Bile Duct. 2013. Available at: Http://www.rcpath.org/ NR/rdonlyres/954273A2-3F01-4B97-B0F6- C136231DF65F/0/dataset histopathologicalreportingcarcinomasmay10.pdf. Accessed December 24, 2013.
13. Maksymov V, Hogan M, Khalifa MA. An anatomical-based mapping analysis of the pancreaticoduodenectomy retroperitoneal margin highlights the urgent need for standardized assessment. HPB (Oxford). 2013;15:218-223.
14. Nakao A, Takeda S, Sakai M, et al. Extended radical resection versus standard resection for pancreatic cancer: The rationale for extended radical resection. Pancreas. 2004;28:289-292.
15. Yeo CJ, Cameron JL, Sohn TA, et al. Pancreaticoduodenectomy with or without extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma: Comparison of morbidity and mortality and short-Term outcome. Ann Surg. 1999;229:613-622; discussion 622-4.
16. Riall TS, Cameron JL, Lillemoe KD, et al. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma-part 3: Update on 5-year survival. J Gastrointest Surg. 2005;9:1191-1204; discussion 1204-6.
17. American Joint Committee on Cancer. Exocrine pancreas. In: Edge S, Byrd DR, Compton CC, et al, eds. AJCC Cancer Staging Manual. Chicago: Springer; 2009:241-249.
18. College of American Pathologists. Pancreas (exocrine). 2012. Available at: Http://www.cap.org/apps/docs/committees/cancer/ cancer-protocols/2013/ PancreasExo-13protocol-3201.pdf. Accessed December 24, 2013.
19. Verbeke CS, Gladhaug IP. Authors' reply: Resection margin involvement and tumour origin in pancreatic head cancer (Br J Surg 2012; 99: 1036-1049). Br J Surg. 2013;100:299.
20. Esposito I, Kleeff J, Bergmann F, et al. Most pancreatic cancer resections are R1 resections. Ann Surg Oncol. 2008;15:1651-1660.
21. Schlitter AM, Esposito I. Definition of microscopic tumor clearance (R0) in pancreatic cancer resections. Cancers (Basel). 2010;2: 2001-2010.
22. Gonzalez RS, Saka B, Bagci P, et al. Neoplasms and pseudotumors associated with low (intrapancreatic) union of cystic duct into common bile duct: A clinicopathologic analysis of 15 cases of a hitherto unrecognized phenomenon (abstract). Mod Pathol. 2013; 26(2S):424A.
23. Adsay NV, Basturk O, Altinel D, et al. The number of lymph nodes identified in a simple pancreatoduodenectomy specimen: Comparison of conventional vs orange-peeling approach in pathologic assessment. Mod Pathol. 2009;22:107-112.
24. Khalifa MA, Maksymov V, Rowsell C. Retroperitoneal margin of the pancreaticoduodenectomy specimen: Anatomic mapping for the surgical pathologist. Virchows Arch. 2009;454:125-131.
25. Porembka MR, Hawkins WG, Linehan DC, et al. Radiologic and intraoperative detection of need for mesenteric vein resection in patients with adenocarcinoma of the head of the pancreas. HPB (Oxford). 2011;13:633-642.
26. Bandyopadhyay S, Basturk O, Coban I, et al. Isolated solitary ducts (naked ducts) in adipose tissue: A specific but underappreciated finding of pancreatic adenocarcinoma and one of the potential reasons of understaging and high recurrence rate. Am J Surg Pathol. 2009;33:425-429.
27. Adsay NV, Bagci P, Tajiri T, et al. Pathologic staging of pancreatic, ampullary, biliary, and gallbladder cancers: Pitfalls and practical limitations of the current AJCC/UICC TNM staging system and opportunities for improvement. Semin Diagn Pathol. 2012;29:127-141.
28. Adsay V, Ohike N, Tajiri T, et al. Ampullary region carcinomas: Definition and site specific classification with delineation of four clinicopathologically and prognostically distinct subsets in an analysis of 249 cases. Am J Surg Pathol. 2012;36:1592-1608.
29. Adsay NV, Zamboni G. Paraduodenal pancreatitis: A clinicopathologically distinct entity unifying "cystic dystrophy of heterotopic pancreas", "para-duodenal wall cyst", and "groove pancreatitis". Semin Diagn Pathol. 2004;21:247-254.
30. Oliva I, Bandyopadhyay S, Coban I, et al. Peripancreatic soft tissue involvement by pancreatic ductal adenocarcinomas: Incidence, patterns and significance (abstract). Mod Pathol. 2009;22:318A.
31. Rau BM, Moritz K, Schuschan S, et al. R1 resection in pancreatic cancer has significant impact on long-Term outcome in standardized pathology modified for routine use. Surgery. 2012;152 (suppl 1):S103-S111.
32. Adsay NV, Basturk O, Saka B. Pathologic staging of tumors: Pitfalls and opportunities for improvements. Semin Diagn Pathol. 2012;29: 103-108.
33. Bosman FT, Carneiro F, Hruban RH, et al. WHO Classification of Tumors of Digestive System. Lyon: WHO Press; 2010.
34. Kawamoto S, Shi C, Hruban RH, et al. Small serotonin-producing neuroendocrine tumor of the pancreas associated with pancreatic duct obstruction. Am J Roentgenol. 2011;197:W482-W488.
35. Kenney B, Singh G, Salem RR, et al. Pseudointraductal papillary mucinous neoplasia caused by microscopic periductal endocrine tumors of the pancreas: A report of 3 cases. Hum Pathol. 2011;42:1034-1041.
36. Shi C, Siegelman SS, Kawamoto S, et al. Pancreatic duct stenosis secondary to small endocrine neoplasms: A manifestation of serotonin productioñ Radiology. 2010;257:107-114.
37. Ohike N, Kim GE, Tajiri T, et al. Intra-Ampullary papillary-Tubular neoplasm (IAPN): Characterization of tumoral intraepithelial neoplasia occurring within the ampulla: A clinicopathologic analysis of 82 cases. Am J Surg Pathol. 2010;34:1731-1748.
38. Gonzalez RS, Bagci P, Kong KT, et al. Distal common bile duct adenocarcinoma: Analysis of 47 cases and comparison with pancreatic and ampullary ductal carcinomas (abstract).Mod Pathol. 2012;25:109A.
39. Saka B, Bagci P, Krasinskas A, et al. Duodenal carcinomas of nonampullary origin are significantly more aggressive than ampullary carcinomas (abstract). Mod Pathol. 2013;26(2S):176A.
40. Adsay NV, Basturk O, Klimstra DS, et al. Pancreatic pseudotumors: Non-neoplastic solid lesions of the pancreas that clinically mimic pancreas cancer. Semin Diagn Pathol. 2004;21:260-267.
41. Altinel D, Basturk O, Sarmiento JM, et al. Lipomatous pseudohypertrophy of the pancreas: A clinicopathologically distinct entity. Pancreas. 2010;39:392-397.